Abstract:AIM To compare the inhibitive effect on gastric acid after a single dose of rabeprazole 10,20 mg, esomeprazole 20,40 mg in healthy H. pylori (Hp)-negative subjects. METHODS This was a randomized, multi-center,open-label, single-dose, four-way crossover study. Each subject received a single dose of rabeprazole 10 mg and 20 mg, esomeprazole 20 mg and 40 mg, respectively. 24-h intragastric pH was monitored simultaneously. There were 14 d washout time before taking the medication. Parameters included basic pH, the onset time of pH ＞ 4 after the medication, daytime recording time (09:00-22:00) and nighttime recording time(22:00-8:00), the median value and the time spent of pH ＞ 4 in daytime recording and night time recording, acid breakthrough time (pH ＜ 4) during the night time. RESULTS There were no difference of the median values of intragastric pH before and after drug administration. Both rabeprazole and esomeprazole in different single dosages can take inhibitive effect in 3 h. The onset time of rabeprazole in 10 mg and 20 mg was significantly faster than that of esomeprazole in 20 mg and 40 mg( P ＜ 0.05) respectively. Except the median value of rabeprazole 20 mg and esomeprazole 40 mg was longer than that in esomeprazole 20 mg, there was no significant difference of intragastric pH ＞ 4 in any other dosage. There was no significant difference of the time spent of pH ＞ 4 in daytime among all drug administrations of rabeprazole and esomeprazole. However, the time spent of pH ＞ 4 in nighttime of rabeprazole 20 mg was significantly longer than that of esomeprazole 20 mg( P ＜ 0.01) and 40 mg( P ＜ 0.05). It was found that the time spent of pH ＞ 4 in nighttime of rabeprazole 10 mg was significantly longer than that of esomeprazole 20 mg ( P ＜ 0.01 ).The nocturnal acid breakthrough (NAB) time of rabeprazole 20 mg was significantly shorter than that of esomeprazole 20 mg ( P ＜ 0.01) and 40 mg( P ＜ 0.05). The acid breakthrough time during the nighttime in rabeprazole 10 mg and esomeprazole 40 mg was significantly shorter than that in esomeprazole 20 mg( P ＜ 0.05). But there were no significant differences among other drug administrations. CONCLUSION Single dose rabeprazole in 10 mg and 20 mg and esomeprazole in 20 mg and 40 mg both can effectively inhibit gastric acid in Hp negative healthy volunteers. However, the rabeprazole takes effect more quickly and has stronger acid inhibitive effect at nighttime in comparion with esomeprazole, rabeprazole is more appropriate in controlling NAB.

Effect of Esomeprazole and Rabeprazole on Intragastric Ph in Healthy Chinese: an Open, Randomized Crossover Trial

Comparison of the inhibitive effect on gastric acid between single dose rabeprazole and esomeprazole in healthy volunteers

Pharmacodynamic Effects and Kinetic Disposition of Rabeprazole in Relation to CYP2C19 Genotype in Healthy Chinese Subjects1

Effect of esomeprazole on intragastric pH in healthy Chinese with different CYP2C19 genotypes

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.

Acid-suppressive Effects of Rabeprazole: Comparing 10mg and 20mg Twice Daily in Japanese Helicobacter Pylori-Negative and -Positive CYP2C19 Extensive Metabolisers

Effect of CYP2C19 genotypes on the pharmacokinetic/pharmacodynamic relationship of rabeprazole after a single oral dose in healthy Chinese volunteers

Comparison on relief of symptoms and acid suppression of Rabeprazole and Omeprazole on reflux esophagitis in aged

Efficacy of Rabeprazole Versus Omerpazole for Acid Suppression in Patients with Duodenal Ulcer: a Multicenter, Randomized, Double-Blind Clinical Trial

Acid-suppressive effects of generic omeprazole: comparison of three brands of generic omeprazole with original omeprazole.

Different dose of new generation proton pump inhibitors for the treatment of Helicobacter pylori infection: A meta-analysis

The Prevention of Upper Gastrointestinal Bleeding in Seriously Ill Chinese Patients: A Randomised, Double-Blind Study Evaluating Esomeprazole Vs Cimetidine

A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis

Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis

Dose-response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes

Prevention of upper gastrointestinal bleeding in critically ill Chinese patients: a randomized, double-blind study evaluating esomeprazole and cimetidine

Pharmacogenetics of Esomeprazole or Rabeprazole-Based Triple Therapy in Helicobacter Pylori Eradication in Hong Kong Non-Ulcer Dyspepsia Chinese Subjects

Pharmacodynamics Between a Dual Delayed-Release Formulation of Low-Dose Esomeprazole and Famotidine in Healthy Korean Subjects

Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions

Study of esomeprazole and rabeprazole on 24-hour intragastric acid control in healthy volunteers

Protocol of a Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Probiotics on the Gut Microbiome of Patients with Gastro-Oesophageal Reflux Disease Treated with Rabeprazole.